New Markets Avenue board to convert 53 lakh warrants on July 4
New Markets Avenue Limited's board will meet on July 4, 2026, to approve the conversion of 53,00,000 warrants into equity shares at par for non-promoters. The meeting will also consider the appointment of M/s. Ramesh Chandra Bagdi & Associates as secretarial auditor.

*this image is generated using AI for illustrative purposes only.
New Markets Avenue will convene a board meeting on July 4, 2026, to consider the conversion of 53,00,000 convertible warrants into equity shares. The conversion will be executed at a face value of ₹10 each on a preferential basis to non-promoters. This decision follows a special resolution passed by shareholders at an Extraordinary General Meeting held on July 31, 2025, and subsequent in-principle approval from the BSE dated October 20, 2025.
The meeting will also deliberate on the appointment of M/s. Ramesh Chandra Bagdi & Associates as the secretarial auditor for the company. The agenda includes any other matters with the permission of the chair.
The table below details the warrant holders and the proposed conversion:
| Name of Allottees | Category | No. of warrants held | No. of warrants applied for conversion | No. of Equity Shares allotted |
|---|---|---|---|---|
| Mrs. Chhaya Gaurang Shah | Non-Promoter Public | 1000000 | 1000000 | 1000000 |
| M/s. Mamta Securities Private Limited | Non-Promoter Public | 1000000 | 1000000 | 1000000 |
| M/s. Spring Trade Mercantile Private Limited | Non-Promoter Public | 500000 | 500000 | 500000 |
| Mr. Prakash Bhoorchand Shah | Non-Promoter Public | 1800000 | 1800000 | 1800000 |
| M/s. Plutus Capital Management LLP | Non-Promoter Public | 1000000 | 1000000 | 1000000 |
| TOTAL | 53,00,000 | 53,00,000 | 53,00,000 |
The board meeting is scheduled to take place at the company's registered office in Mumbai. The conversion of warrants will increase the company's equity share capital.
Historical Stock Returns for New Markets Avenue
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +6.07% | +26.60% | +330.05% | +330.05% | +330.05% |
How will the infusion of 5.3 million new equity shares impact the company's earnings per share (EPS) and existing shareholder dilution?
What strategic capital allocation plans does New Markets Avenue intend to pursue following the increase in equity share capital?
How might the market react to the preferential allotment to non-promoters regarding investor confidence and stock liquidity?































